An in vitro experimental study of the effect of fosfomycin in combination with amikacin, ciprofloxacin or meropenem on biofilm formation by multidrug-resistant urinary isolates of Escherichia coli

References

1. Catheter-associated Urinary Tract Infections (CAUTI); 2017 https://www.cdc.gov/hai/ca_uti/uti.html cited 2018 Dec 26
2. Kumar D, Das A, Purbey M, Gupta N, Nath G. Susceptibility of uropathogenic multidrug-resistant Escherichia coli to fosfomycin. J Acad Clin Microbiol 2017; 19:101 [View Article]
   [Google Scholar]
3. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597–602 [View Article]
   [Google Scholar]
4. Brady AJ, Laverty G, Gilpin DF, Kearney P, Tunney M. Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?. J Med Microbiol 2017; 66:461–469 [View Article]
   [Google Scholar]
5. Beloin C, Roux A, Ghigo JM. Escherichia coli biofilms. Curr Top Microbiol Immunol 2008; 322:249–289
   [Google Scholar]
6. Silver LL. Fosfomycin: mechanism and resistance. Cold Spring Harb Perspect Med 2017; 7:a025262 [View Article]
   [Google Scholar]
7. Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ, Fosfomycin VKZ. Fosfomycin. Clin Microbiol Rev 2016; 29:321–347 [View Article]
   [Google Scholar]
8. Shi J, Mao N-F, Wang L, Zhang H-B, Chen Q et al. Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo. PLoS One 2014; 9:e113133 [View Article]
   [Google Scholar]
9. Mikuniya T, Kato Y, Ida T, Maebashi K, Monden K et al. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. J Infect Chemother 2007; 13:285–290 [View Article]
   [Google Scholar]
10. Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC et al. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents 2003; 22 Suppl 2:95–100 [View Article]
    [Google Scholar]
11. Descourouez JL, Jorgenson MR, Wergin JE, Rose WE. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents. Antimicrob Agents Chemother 2013; 57:1518–1520 [View Article]
    [Google Scholar]
12. CLSI Performance Standards for Antibiotic Susceptibility Testing 2017, 27th Edition, CLSI supplement M100. Wayne, PA: Clinical Laboratory Standards Institute; 2017
    [Google Scholar]
13. Lorian V. editor Antibiotics in Laboratory Medicine, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005
    [Google Scholar]
14. Tessier F, Quentin C. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa . Eur J Clin Microbiol Infect Dis 1997; 16:159–162 [View Article]
    [Google Scholar]
15. Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME. Synergy of fosfomycin with other antibiotics for gram-positive and gram-negative bacteria. Eur J Clin Pharmacol 2010; 66:359–368 [View Article]
    [Google Scholar]
16. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22:996–1006
    [Google Scholar]
17. Petersen PJ, Labthavikul P, Jones CH, Bradford PA. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 2006; 57:573–576 [View Article]
    [Google Scholar]
18. Matthews PC, Barrett LK, Warren S, Stoesser N, Snelling M et al. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study. BMC Infect Dis 2016; 16: [View Article]
    [Google Scholar]
19. Evren E, Azap OK, Çolakoğlu Şule, Arslan H, Azap Özlem Kurt, ÖK A. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis 2013; 76:335–338 [View Article]
    [Google Scholar]
20. Cai Y, Fan Y, Wang R, An M-M, Liang B-B. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. J Antimicrob Chemother 2009; 64:563–566 [View Article]
    [Google Scholar]